Henry Prince

The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma

Crystal Gao, Christopher J McCormack, Carrie van der Weyden, Robert Twigger, Odette Buelens, Stephen Lade, Christine Khoo, Belinda A Campbell, Michelle Goh, Penny McKelvie, H Miles Prince

Journal article  |  2021  |  Journal of the American Academy of Dermatology

Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma

Constantine S Tam, Hang Quach, Andrew Nicol, Xavier Badoux, Hannah Rose, H Miles Prince, Michael F Leahy, Richard Eek, Nicholas Wickham, Sushrut S Patil, Jane Huang, Radha Prathikanti, Aileen Cohen, Rebecca Elstrom, William Reed, Jingjing Schneider, Ian W Flinn

Journal article  |  2020  |  Blood Advances

Zanubrutinib (BGB-3111) is a next-generation Bruton tyrosine kinase inhibitor designed to be more selective with fewer off-target ..

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study

Mansi Bhurani, Lorenz Admojo, Carrie Van der Weyden, Robert Twigger, Ali Bazargan, Hang Quach, Allan Zimet, Luke Coyle, Julian Lindsay, Dejan Radeski, Eliza Hawkes, Glen Kennedy, Ian Irving, Naadir Gutta, Judith Trotman, James Yeung, Lindsay Dunlop, Minh Hua, Pratyush Giri, Sam Yuen, et al.

Journal article  |  2020  |  Leukemia & Lymphoma

We present a retrospective multicenter study of pralatrexate treatment outcomes in an Australian practice setting for patients wit..

Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells

Rachel Elizabeth Cooke, Kylie Margaret Quinn, Hang Quach, Simon Harrison, Henry Miles Prince, Rachel Koldej, David Ritchie

Journal article  |  2020  |  Frontiers in Immunology

New diagnoses of multiple myeloma (MM) tend to occur after the age of 60, by which time thymic output is severely reduced. As a co..

Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma

Belinda A Campbell, Julia J Scarisbrick, Youn H Kim, Ryan A Wilcox, Christopher McCormack, H Miles Prince

Journal article  |  2020  |  Cancers

Time to next treatment (TTNT) is an emerging endpoint in clinical studies of primary cutaneous T-cell lymphomas (CTCL), with utili..

Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?

Carrie van der Weyden, Sean Harrop, Henry Miles Prince

Journal article  |  2020  |  Leukemia & Lymphoma

Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia: A Longitudinal Study of Implant and Other Related Risk Factors.

Anna Loch-Wilkinson, Kenneth J Beath, Mark R Magnusson, Rodney Cooter, Karen Shaw, James French, Karen Vickery, H Miles Prince, Anand K Deva

Journal article  |  2020  |  Aesthetic Surgery Journal

BACKGROUND: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging cancer that has been linked to the ..

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

Reinhard Dummer, Henry M Prince, Sean Whittaker, Steven M Horwitz, Youn H Kim, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Herbert Eradat, Lauren Pinter-Brown, Jose A Sanches, Pablo L Ortiz-Romero, Oleg E Akilov, Larisa Geskin, Auris Huen, Jan Walewski, Yinghui Wang, Julie Lisano, Akshara Richhariya, et al.

Journal article  |  2020  |  European Journal of Cancer

BACKGROUND: Brentuximab vedotin was approved for adult patients with CD30-expressing cutaneous T-cell lymphoma treated with prior ..

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study).

P Quaglino, HM Prince, R Cowan, M Vermeer, L Papadavid, M Bagot, O Servitjie, E Berti, E Guenova, R Stadler, C Querfeld, AM Busschots, E Hodak, A Patsatsi, J Sanches, M Maule, J Yoo, M Kevin, P Fava, S Ribero, et al.

Journal article  |  2020  |  British Journal of Dermatology

BACKGROUND: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a prospective analysis of an int..

Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis

Meletios A Dimopoulos, Xavier Leleu, Philippe Moreau, Paul G Richardson, Anna Marina Liberati, Simon J Harrison, H Miles Prince, Enrique M Ocio, Sylvie Assadourian, Frank Campana, Laure Malinge, Dorothee Semiond, Helgi van de Velde, Kwee Yong

Journal article  |  2020  |  Leukemia